After the "chlorotia occupation incident", a joint letter of thousands of people has aroused widespread concern in society

On June 29, the State Drug Administration and the National Health and Health Commission also released two documents: "Clinical Urgent Pharmaceutical Import Work Plan" and "Club Temporary Import Work Plan". The circle of pharmaceutical companies caused a sensation.

"Shima Zhan" caused public opinion last year. In July 2021, parents of rare epilepsy named "Iron Horse Glacier" purchased clotal occupation from overseas and were detained and prosecuted by "suspected drug trafficking". This drug has since become very hot.

This time, the two ministries and commissions specifically published a work plan for a drug, announcing that a group of "sensitive drugs" represented by chloropyocus have since entered the green channel of China.

The Jianzhi Bureau learned that the introduction of these two work plans may be related to a joint letter. It took just half a year to promote the promulgation of a new policy.

On June 28, the day before the introduction of the two programs, the Beijing Union Hospital specially organized an expert meeting. The Jianzhi Bureau learned that Union is one of the lead units. I hope to set the drug import path for the scheme, running through, familiar, and then promoting them to various hospitals.

Several doctors and experts expressed their preferences to the "Plan" to the Jianzhi Bureau. Sun Zhongshi, an expert of the China Hospital Association National Medicine Monitoring Office, sighed to Jianxian Bureau: "This is really a good decision."

From "suspected drug trafficking" to Tong Chang's medicine

The "chlorometer incident" in 2021 has attracted widespread concern because clotal is indeed addictive ingredients.

Shimbhan was originally developed by Danish Lingbei Pharmaceutical. Many companies such as Sanofi also produced, and more than 100 countries were used for broad -spectrum treatment of antiepile seizures. Chopstra has not been listed in China and is listed as the second type of psychotropic drugs. Chinese patients want to use clotal, and there are almost no ways before: overseas purchasing may be suspected of smuggling psychotropic drugs, and even certainty is smuggling drugs.

After the "chlorotia incident", in November 2021, a "How to let our children survive?" "The joint letter has aroused widespread concern in the society, and 1042 families who face the crisis of the" clotic "crisis of the drug crisis jointly wrote a letter.

After the thousands of people's help letter issued, organizations such as rare disease alliances, illness challenges challenged public welfare foundation began to report problems such as the National Health and Health Commission, pharmaceutical regulatory bureau, and government mailboxes from various local governments, and contacted a number of pharmaceutical companies and hospitals. At the same time, the State Drug Administration also communicated with relevant units such as the China Anesthesi Medicine Association to discuss the way of seeking solutions for the family members of these children.

Wang Yiou, the founder and vice chairman of Beijing Disease Pain Challenge the Charity Foundation, told Jianxian Bureau: "Under the coordination of the China Rare Disease Alliance, we have helped do some submitted work, and the relevant departments attach more attention." Some of the rare epilepsy groups were partially found and surveyed, and the regional distribution and medication of patients were investigated, and more than 1,000 patient samples were finally collected.

The survey was completed in January 2022. Wang Yiou clearly remembered that after this round of bottom, the State Health and Health Commission soon went to the pharmaceutical supervision bureau, customs and other departments to discuss the solution to the problem. On March 29, the National Health and Health Commission publicly solicited opinions on the "Clinical Urgent Pharmaceutical Import Work Plan" and "Clotic Temporary Import Work Plan".

During the comments, the incident had changed. On April 15, 2022, the above -mentioned "Iron Horse Glacier" suspected of smuggling club -occupying was taken for a bail pending trial.

When the final plan is implemented, 3 types of medicines can take green channels in the future: including drugs for treating rare diseases; drugs that are used to prevent severe life diseases and have no effective treatment or preventive means; , And medicine with obvious clinical advantages.

Long Tianwei, Chief Medicine and Innovation Officer of the Challenge of the Pain Challenge, said: "In the rare disease field, there are many drugs abroad and there are many drugs in China.

This means that in the future, domestic imports of urgent need of drugs will be changed from a few open pilot areas to national hospitals. As long as there is a reasonable need for medication, the hospital can temporarily import drugs through application, approval and other processes.

On the day of the "Plan", the happiest is the rare sick families with useful medicines. "Everyone is excited to have a compliance and legal drug passage. Once this channel is opened, it is a particularly good thing for the rare disease groups that need to be used in urgent need of medication." Wang Yiou told Jianzhi Bureau.

The landing is inseparable from hospitals and enterprises

The two "Plan" set off a lot of water in the clinician group.

Zou Zhaochun, deputy head of the rare disease group of the Children's Hospital of Zhejiang University Medical College, and the deputy leader of the rare disease group of the Children's Science Branch of the Chinese Medical Association, noticed the good news for the first time. Zou Chaochun has studied for rare diseases such as children's growth and development, obesity and metabolic syndrome, sticky polysaccharide storage, and blood lipid metabolic disorders. It often comes to treat patients with rare diseases in various places.

Zou Zhaochun told Jianzhi Bureau: "The country provides at least such a new way, and many parents can try it to try it. The original road is basically unreasonable."

It is not easy to enter the hospital urgently to enter the hospital. A realistic question is whether the hospital is willing to buy some expensive rare diseases after the policy is opened. Some doctors believe: "There will be a lot of considerations in the hospital in the hospital, and the proportion of medicines is very dead, so some hospitals are not very positive for the use of these drugs."

Chen Tong, a clinical surgeon in Beijing, also expressed similar confusion: "Doctors, hospital leaders, and administrative staff of the clinical department. Are they motivated to promote the real implementation of temporary imported drugs?"

Wang Yiou is still more optimistic. Judging from past experience, most of the rare diseases that are urgently needed in clinical are not expensive, and many are old medicines that have been listed overseas for many years.

Enterprises also look forward to the implementation of the plan. After the import processes are simplified, the drugs can enter China faster, the cost is lower, and the clinical data can be accumulated. Many business people told the Jianzhi Bureau that the enterprise has enough enthusiasm and the hospital to promote the implementation of the plan.

Chen Haochang, vice president and general manager of Jeterbein Greater China, told Jianxian Bureau: "The rare diseases we listed abroad need to introduce China at least 5-8 years. Accelerate access to allow drugs to introduce the medicine In China, patients can get benefits "

In the past, companies like Geterbein wanted to quickly introduce varieties. The best choice was to take the pioneer zone of Boao Le, Hainan.

After the plan is introduced, many people will compare it with the pharmaceutical implementation policy in the Boao Pioneer District. Public information shows that since 2022, more than ten clinical urgently needed imports of imports of imports of Boao Le City.

An industry insider analyzed the Jianzhi Bureau that Boao Yuecheng will have a certain solution to imported drugs that are urgently needed by clinical clinicals, but relatively long process, medical, hospitals, and experts are relatively limited, and chlorophards are like such special drugs It is not among the scope of "first trial" in Boao Lecheng.

The plan launched by the two ministries and commissions uses all medical institutions as the main body of the application, which can solve the problem of medication for domestic patients in a larger scale.

"Every small group should not be abandoned." If the words that moved countless people when the medical insurance negotiated in 2021 said, they should not be abandoned and would not be abandoned.

### Rare Disease#

- END -